Enteric α-defensins contribute to intestinal mucosal immunity against SARS-CoV-2 infection.
It is suggested that enteric α-defensins help alleviate, as host protective factors, Covid-19 symptoms in the intestine despite higher ACE2 expression in the gut than in the lungs, and that Crp5 may be developed as a broad-spectrum antiviral for the treatment of coronavirus infection irrespective of virus type and vari...